Swati Bhayana Leads Breakthrough Pediatric Sickle Cell Cure in India
Swati Bhayana, Consultant at Fortis Healthcare, shared a post by Biomall.in on LinkedIn:
”Gratitude to the amazing team of doctors, nurses, hospital management who supported endlessly for the dream
– We are the force.”
Quoting Biomall.in’s post:
”Hope for Sickle Cell: A Breakthrough in India’s Pediatric Care
India marks a major milestone in the fight against Sickle Cell Disease (SCD) with a decade-long clinical study demonstrating the transformative potential of pediatric stem-cell transplantation.
Led by Dr. SWATI BHAYANA, a leading pediatric hematologist at Fortis Healthcare Gurugram, the team has reported remarkable outcomes:~87% overall survival rate among children undergoing stem-cell transplant 96% survival when the donor is a matched sibling, Significant reduction in long-term complications, and improved quality of life
This achievement brings India closer to offering globally benchmarked curative therapy, especially critical for high-burden tribal and underserved regions. It underscores the power of clinical innovation, strong donor-matching programs, and advanced transplant care in reshaping SCD management.
Read the full article here.”
Title: Indian Healthcare Achieves Global Standards in Pediatric SCD Cure
Stay informed with Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology